171 related articles for article (PubMed ID: 17277733)
1. Mood disorder in a patient with Smith-Magenis syndrome: a case report.
Bersani G; Russo D; Limpido L; Marconi D
Neuro Endocrinol Lett; 2007 Feb; 28(1):7-10. PubMed ID: 17277733
[TBL] [Abstract][Full Text] [Related]
2. Detection and delineation of an unusual 17p11.2 deletion by array-CGH and refinement of the Smith-Magenis syndrome minimum deletion to approximately 650 kb.
Schoumans J; Staaf J; Jönsson G; Rantala J; Zimmer KS; Borg A; Nordenskjöld M; Anderlid BM
Eur J Med Genet; 2005; 48(3):290-300. PubMed ID: 16179224
[TBL] [Abstract][Full Text] [Related]
3. Smith-Magenis syndrome.
Elsea SH; Girirajan S
Eur J Hum Genet; 2008 Apr; 16(4):412-21. PubMed ID: 18231123
[TBL] [Abstract][Full Text] [Related]
4. [Smith-Magenis syndrome: a report of two new cases and an approximation to their characteristic behavioural phenotype].
Blanco-Barca O; Gallego-Blanco M; Ruiz-Ponte C; Barros-Angueira F; Esquete-López C; Eirís-Puñal J; Castro-Gago M
Rev Neurol; 2004 Jun 1-15; 38(11):1038-42. PubMed ID: 15202082
[TBL] [Abstract][Full Text] [Related]
5. Reduced penetrance of craniofacial anomalies as a function of deletion size and genetic background in a chromosome engineered partial mouse model for Smith-Magenis syndrome.
Yan J; Keener VW; Bi W; Walz K; Bradley A; Justice MJ; Lupski JR
Hum Mol Genet; 2004 Nov; 13(21):2613-24. PubMed ID: 15459175
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of risperidone treatment in Smith-Magenis syndrome (del 17 pll. 2).
Niederhofer H
Psychiatr Danub; 2007 Sep; 19(3):189-92. PubMed ID: 17914318
[TBL] [Abstract][Full Text] [Related]
7. A Turkish patient with large 17p11.2 deletion presenting with Smith Magenis syndrome.
Tug E; Cine N; Aydin H
Genet Couns; 2011; 22(1):11-9. PubMed ID: 21614983
[TBL] [Abstract][Full Text] [Related]
8. An individual with Gilles de la Tourette syndrome and Smith-Magenis microdeletion syndrome: is chromosome 17p11.2 a candidate region for Tourette syndrome putative susceptibility genes?
Shelley BP; Robertson MM; Turk J
J Intellect Disabil Res; 2007 Aug; 51(Pt 8):620-4. PubMed ID: 17598875
[TBL] [Abstract][Full Text] [Related]
9. A physical map of the mouse shaker-2 region contains many of the genes commonly deleted in Smith-Magenis syndrome (del17p11.2p11.2).
Probst FJ; Chen KS; Zhao Q; Wang A; Friedman TB; Lupski JR; Camper SA
Genomics; 1999 Feb; 55(3):348-52. PubMed ID: 10049592
[TBL] [Abstract][Full Text] [Related]
10. Three young children with Smith-Magenis syndrome: their distinct, recognisable behavioural phenotype as the most important clinical symptoms.
Willekens D; De Cock P; Fryns JP
Genet Couns; 2000; 11(2):103-10. PubMed ID: 10893661
[TBL] [Abstract][Full Text] [Related]
11. Inverted rhythm of melatonin secretion in Smith-Magenis syndrome: from symptoms to treatment.
De Leersnyder H
Trends Endocrinol Metab; 2006 Sep; 17(7):291-8. PubMed ID: 16890450
[TBL] [Abstract][Full Text] [Related]
12. Genomic organisation of the approximately 1.5 Mb Smith-Magenis syndrome critical interval: transcription map, genomic contig, and candidate gene analysis.
Lucas RE; Vlangos CN; Das P; Patel PI; Elsea SH
Eur J Hum Genet; 2001 Dec; 9(12):892-902. PubMed ID: 11840190
[TBL] [Abstract][Full Text] [Related]
13. Hemizygosity for the COP9 signalosome subunit gene, SGN3, in the Smith-Magenis syndrome.
Elsea SH; Mykytyn K; Ferrell K; Coulter KL; Das P; Dubiel W; Patel PI; Metherall JE
Am J Med Genet; 1999 Dec; 87(4):342-8. PubMed ID: 10588842
[TBL] [Abstract][Full Text] [Related]
14. Smith-Magenis syndrome in Puerto Rico: a case report.
Jardón J; Izquierdo NJ
Bol Asoc Med P R; 2009; 101(2):59-61. PubMed ID: 19954105
[TBL] [Abstract][Full Text] [Related]
15. Sleep disturbance in Smith-Magenis syndrome (del 17 p11.2).
Smith AC; Dykens E; Greenberg F
Am J Med Genet; 1998 Mar; 81(2):186-91. PubMed ID: 9613860
[TBL] [Abstract][Full Text] [Related]
16. Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome.
Chen KS; Manian P; Koeuth T; Potocki L; Zhao Q; Chinault AC; Lee CC; Lupski JR
Nat Genet; 1997 Oct; 17(2):154-63. PubMed ID: 9326934
[TBL] [Abstract][Full Text] [Related]
17. Interstitial 6q deletion: clinical and array CGH characterisation of a new patient.
Le Caignec C; Swillen A; Van Asche E; Fryns JP; Vermeesch JR
Eur J Med Genet; 2005; 48(3):339-45. PubMed ID: 16179229
[TBL] [Abstract][Full Text] [Related]
18. Mutations in RAI1 associated with Smith-Magenis syndrome.
Slager RE; Newton TL; Vlangos CN; Finucane B; Elsea SH
Nat Genet; 2003 Apr; 33(4):466-8. PubMed ID: 12652298
[TBL] [Abstract][Full Text] [Related]
19. Microdeletion on 17p11.2 in a Smith-Magenis syndrome patient with mental retardation and congenital heart defect: first report from China.
Huang C; Yang YF; Zhang H; Xie L; Chen JL; Wang J; Tan ZP; Luo H
Genet Mol Res; 2012 Aug; 11(3):2321-7. PubMed ID: 22911601
[TBL] [Abstract][Full Text] [Related]
20. Smith-Magenis syndrome with West syndrome in a 5-year-old girl: a long-term follow-up study.
Hino-Fukuyo N; Haginoya K; Uematsu M; Nakayama T; Kikuchi A; Kure S; Kamada F; Abe Y; Arai N; Togashi N; Onuma A; Tsuchiya S
J Child Neurol; 2009 Jul; 24(7):868-73. PubMed ID: 19264735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
